Sean W. Dooling

Sean W. Dooling

Auto-generated profile, based on publicly available information

Sean W. Dooling

Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA; Memory and Brain Research Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Neuron
Verified
Journal Article
Closed access
MSMartina Sgritta
Martina Sgritta
SDSean W. Dooling
Sean W. Dooling
SBShelly A. Buffington
Shelly A. Buffington
EMEric N. Momin
Eric N. Momin
MFMichael B. Francis
Michael B. Francis
MCMauro Costa-Mattioli
Mauro Costa-Mattioli

10 March 2021 in Cell
Verified
Journal Article
Closed access
SBShelly A. Buffington
Shelly A. Buffington
SDSean W. Dooling
Sean W. Dooling
MSMartina Sgritta
Martina Sgritta
CNCecilia Noecker
Cecilia Noecker
OMOscar D. Murillo
Oscar D. Murillo
MCMauro Costa-Mattioli
Mauro Costa-Mattioli

15 November 2019 in Science
Verified
Journal Article
Closed access
PDF file
PZPing Jun Zhu
Ping Jun Zhu
SKSanjeev Khatiwada
Sanjeev Khatiwada
YCYa Cui
Ya Cui
LRLucas C. Reineke
Lucas C. Reineke
SDSean W. Dooling
Sean W. Dooling
MCMauro Costa-Mattioli
Mauro Costa-Mattioli
Tuning stress protects cognition: Down syndrome (DS) is a chromosomal disorder that occurs when a person has an extra copy of chromosome 21. DS causes intellectual disabilities, among other health issues, but little is known about the mechanisms underlying the memory deficits in DS. Zhu et al. used a multidisciplinary approach to show that a defect in integrated stress response, a conserved pathway that controls protein homeostasis, can explain the cognitive and neuronal deficits in a mouse model of DS (see the Perspective by Halliday and Mallucci). These insights into the biological basis underlying DS could potentially help in the design of treatments for this condition. Science , this issue p. 843 ; see also p. 797

23 June 2023 in Science Advances
Verified
Journal Article
Open access
YZYin Zhai
Yin Zhai
JPJohn P. Pribis
John P. Pribis
SDSean W. Dooling
Sean W. Dooling
LVLibertad Garcia Villada
Libertad Garcia Villada
PMP.J. Minnick
P.J. Minnick
SRSusan M Rosenberg
Susan M Rosenberg
Evolution of antibiotic resistance is a world health crisis, fueled by new mutations. Drugs to slow mutagenesis could, as cotherapies, prolong the shelf-life of antibiotics, yet evolution-slowing drugs and drug targets have been underexplored and ineffective. Here, we used a network-based strategy to identify drugs that block hubs of fluoroquinolone antibiotic-induced mutagenesis. We identify a U.S. Food and Drug Administration– and European Medicines Agency–approved drug, dequalinium chloride (DEQ), that inhibits activation of the Escherichia coli general stress response, which promotes ciprofloxacin-induced (stress-induced) mutagenic DNA break repair. We uncover the step in the pathway inhibited: activation of the upstream “stringent” starvation stress response, and find that DEQ slows evolution without favoring proliferation of DEQ-resistant mutants. Furthermore, we demonstrate stress-induced mutagenesis during mouse infections and its inhibition by DEQ. Our work provides a proof-of-concept strategy for drugs to slow evolution in bacteria and generally.

1 July 2018 in Cell Host & Microbe
Verified
Journal Article
Closed access
SDSean W. Dooling
Sean W. Dooling
MCMauro Costa-Mattioli
Mauro Costa-Mattioli

2 April 2026 in Science
Verified
Journal Article
Closed access
LRLucas C. Reineke
Lucas C. Reineke
PZPing Jun Zhu
Ping Jun Zhu
UDUdit Dalwadi
Udit Dalwadi
SDSean W. Dooling
Sean W. Dooling
YLYuwei Liu
Yuwei Liu
MCMauro Costa-Mattioli
Mauro Costa-Mattioli
The integrated stress response (ISR) is essential for cellular homeostasis and cognitive function. We investigated how persistent ISR activation affects cognitive performance by studying the PPP1R15B R658C genetic variant associated with intellectual disability. To model this condition, we generated a mouse line with the pathogenic allele inserted. This variant destabilized the PPP1R15B•PP1 phosphatase complex, causing persistent ISR activation, impaired protein synthesis, and long-term memory deficits. We demonstrated that the cognitive and synaptic impairments in Ppp1r15b R658C mice arise directly from ISR activation. Furthermore, we characterized DP71L, a viral ortholog of PPP1R15B, which acted as a potent pan-ISR inhibitor. DP71L reversed the cognitive and synaptic deficits across mouse models of Down syndrome, Alzheimer’s disease, and aging, and enhanced synaptic plasticity and memory in healthy mice.